The objective of this review is to describe, in accordance with the current literature, the demographic-clinical characteristics, pharmacological and non-pharmacological treatments in the cognitive changes developed after infection by the SARS-CoV-2. Method, we conducted a non-systematic search in MEDLINE (PubMed) with the aim of finding bibliography including original studies describing current concepts in clinical definitions, pathophysiology, clinical features and therapeutic strategies. Utilizing MeSH terminology, including articles published since 2020. Results, associated risk factors of cognitive decline include female sex, chronic diseases, smoking, and history of hospitalization. Frequently affected cognitive domains are memory, attention, and executive function. Less commonly, language and visuospatial function is reported. Functional and structural imaging has demonstrated ana...